Research

Presently, Interpath has in research mode several new products for the relief of pain and inflammation and the promotion of joint health in animals and humans.

Interpath initiated two large-scale research trials, which were conducted on Interpath’s behalf at Guelph University, Ontario, Canada. Ongoing research will be undertaken by Australian Universities inconjunction with some adjuct work with international facilities.

The first stage of the invitro research project has been completed. Results of the trial have been outstanding with efficacy clearly being demonstrated on the original Sasha’s Blend formulation. (Pearson et al., 2007. In addition the novel and powerful properties of our ‘new’ active have been proven.

The second stage, a large-scale trial in equine has also concluded. Interpath is very proud of the non-invasive format of the live studies. All horses returned to full health at the conclusion of the trial and were returned to owners happy and with healthy joints. Again the results of the equine study were exceptional.   The research paper on this study is yet to be published.

The exciting results from the invitro and invivo trials enables Interpath to launch a new range of products over the coming years.

It is important to have product specific scientific data. Professional products need to demonstrate efficacy and safety. This cannot always adequately be achieved by utilising prior studies conducted by other facilities on actives, which may not necessarily be identical to the actives in the new products formulation. Interpath's research is conducted specifically on its own products. This is unique and positions Interpath products ahead of competitors.

Research Articles

Interpath have recently released the findings of several research studies on 'Anti-inflammatory and chondroprotective effects of nutraceuticals from Sashas Blend in a cartilage explant model of inflammation'.  >read more/x-tad-bigger>/fontfamily>